Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.70)
# 1,724
Out of 5,182 analysts
310
Total ratings
59.03%
Success rate
-0.82%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Initiates: Equal-Weight | $28 | $25.70 | +8.95% | 1 | Mar 30, 2026 | |
| OMDA Omada Health | Maintains: Overweight | $32 → $30 | $14.72 | +103.80% | 2 | Mar 6, 2026 | |
| VEEV Veeva Systems | Maintains: Equal-Weight | $205 → $215 | $160.45 | +34.00% | 11 | Mar 5, 2026 | |
| HIMS Hims & Hers Health | Maintains: Equal-Weight | $40 → $21 | $29.39 | -28.55% | 5 | Feb 25, 2026 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $5 → $4 | $2.28 | +75.44% | 3 | Dec 18, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $11 → $6 | $6.14 | -2.28% | 6 | Dec 18, 2025 | |
| HCA HCA Healthcare | Downgrades: Underweight | $425 | $445.77 | -4.66% | 5 | Dec 15, 2025 | |
| ARDT Ardent Health | Downgrades: Equal-Weight | $22 → $12 | $10.04 | +19.52% | 3 | Nov 14, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $57 → $67 | $45.03 | +48.79% | 3 | Sep 23, 2025 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $215.00 | -33.02% | 15 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $175 → $210 | $185.53 | +13.19% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $200 | $179.51 | +11.41% | 1 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $1.01 | +395.05% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $62.12 | +83.52% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $42.25 | +34.91% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $86.84 | -6.73% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $24.66 | +41.93% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.18 | +4.77% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $85.84 | +115.52% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $209.52 | -20.29% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $148.64 | -71.74% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $196.63 | -19.14% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $78.36 | +59.52% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $418.20 | -82.71% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $269.50 | -27.64% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $354.69 | +37.58% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $179.22 | +65.16% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $263.43 | +39.70% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $223.62 | +129.41% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $282.58 | -2.68% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $43.50 | +102.30% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $98.04 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $91.73 | +101.68% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $236.87 | -10.08% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $122.12 | -52.51% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $392.59 | -70.20% | 15 | Jun 16, 2020 |
Waystar Holding
Mar 30, 2026
Initiates: Equal-Weight
Price Target: $28
Current: $25.70
Upside: +8.95%
Omada Health
Mar 6, 2026
Maintains: Overweight
Price Target: $32 → $30
Current: $14.72
Upside: +103.80%
Veeva Systems
Mar 5, 2026
Maintains: Equal-Weight
Price Target: $205 → $215
Current: $160.45
Upside: +34.00%
Hims & Hers Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $40 → $21
Current: $29.39
Upside: -28.55%
GoodRx Holdings
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.28
Upside: +75.44%
American Well
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $11 → $6
Current: $6.14
Upside: -2.28%
HCA Healthcare
Dec 15, 2025
Downgrades: Underweight
Price Target: $425
Current: $445.77
Upside: -4.66%
Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22 → $12
Current: $10.04
Upside: +19.52%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57 → $67
Current: $45.03
Upside: +48.79%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $215.00
Upside: -33.02%
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $185.53
Upside: +13.19%
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $179.51
Upside: +11.41%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $1.01
Upside: +395.05%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $62.12
Upside: +83.52%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $42.25
Upside: +34.91%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $86.84
Upside: -6.73%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $24.66
Upside: +41.93%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $17.18
Upside: +4.77%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $85.84
Upside: +115.52%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $209.52
Upside: -20.29%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $148.64
Upside: -71.74%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $196.63
Upside: -19.14%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $78.36
Upside: +59.52%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $418.20
Upside: -82.71%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $269.50
Upside: -27.64%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $354.69
Upside: +37.58%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $179.22
Upside: +65.16%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $263.43
Upside: +39.70%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $223.62
Upside: +129.41%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $282.58
Upside: -2.68%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $43.50
Upside: +102.30%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $98.04
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $91.73
Upside: +101.68%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $236.87
Upside: -10.08%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $122.12
Upside: -52.51%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $392.59
Upside: -70.20%